Experienced Management Team
Marvel Biotechnology Inc. is at the forefront of modern pharmaceutical re-purposing technology.
Lead by the dynamic team of Rod Matheson and Mark Williams PhD MBA, Marvel is committed to providing maximum value to it’s shareholders while keeping a laser sharp focus on leading the way to new discoveries in science.
Mark Williams PhD MBA
CHIEF SCIENCE OFFICER, DIRECTOR
With over 15 years of experience in drug and medical device development Mark joins the Marvel team with an incredible list of accolades.
Author of more than 12 patents, Mark brings his vast expertise in taking companies from discovery to Phase II trials including manufacturing and toxicology.
He is the Co-founder of three companies held privately (sold), as well as on NASDAQ and CSE markets.
PRESIDENT AND CEO, DIRECTOR
With over 35 years experience in the investment and capital markets industries, Rod provides the experience of a seasoned senior executive as Vice-President and Director with Wood Gundy, Canaccord Capital, Bolder Investment Partners and independent advisor with Aligned Capital Partners Inc. until late 2019. A significant amount of Rod’s career has been spent in capital markets advisory and risk management services with a specialized focus in the life sciences sector. Rod has completed multiple financings of over $1B in both private and public companies. In late 2019 Rod commenced the operation of Renaissance Mercantile Corp. as Executive Chairman, a privately owned merchant bank.
Experienced Management, Proven Success.
The Marvel Model was built on a proven system designed to maximize capital in order to achieve the greatest results.